Abstract
From time to time it has been proposed that the international pharmaceutical enterprise, perhaps including other organizations along with corporations, consider establishing one or more semiautonomous institutes to conduct analyses and convene forums on a variety of generic, nonproprietary issues. In analogous enterprises (such as those described below), institutes of this kind render substantial public service.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lowrance, W.W. (1989). Industry-Sponsored Risk Institutes. In: Horisberger, B., Dinkel, R. (eds) The Perception and Management of Drug Safety Risks. Health Systems Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74272-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-74272-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74274-3
Online ISBN: 978-3-642-74272-9
eBook Packages: Springer Book Archive